FCF Yield % is calculated as Free Cash Flow divided by Market Capitalization. It is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.
The historical rank and industry rank for Jia Jie Biomedical Co's FCF Yield % or its related term are showing as below:
ROCO:4109'
s FCF Yield % Range Over the Past 10 Years
Min: -7.13 Med: -0.88 Max: 4.56
Current: -4.44
During the past 13 years, the highest FCF Yield % of Jia Jie Biomedical Co was 4.56%. The lowest was -7.13%. And the median was -0.88%.
ROCO:4109's FCF Yield % is ranked worse than 73.68% of 1983
companies
in the Consumer Packaged Goods industry
Industry Median: 2.05
vs ROCO:4109: -4.44
Similar to Earnings Yield %, FCF Yield % is financial solvency ratio. A lower ratio suggests a less attractive investment, indicating that investors might not receive substantial returns in proportion to their investment. Conversely, a high free cash flow yield signals that a company generates sufficient cash to comfortably meet its debts, obligations, and dividend payments, making it a promising investment choice.
Jia Jie Biomedical Co FCF Yield % Related Terms
Jia Jie Biomedical Co FCF Yield % Historical Data
* Premium members only.
The historical data trend for Jia Jie Biomedical Co's FCF Yield % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Packaged Foods subindustry, Jia Jie Biomedical Co's FCF Yield %, along with its competitors' market caps and FCF Yield % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Jia Jie Biomedical Co FCF Yield % vs Consumer Packaged Goods Industry
For the Consumer Packaged Goods industry and Consumer Defensive sector, Jia Jie Biomedical Co's FCF Yield % distribution charts can be found below:
* The bar in red indicates where Jia Jie Biomedical Co's FCF Yield % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Jia Jie Biomedical Co (ROCO:4109) has a FCF Yield % of -4.44 as of Jul. 08, 2026. FCF Yield is calculated as Free Cash Flow divided by Market Capitalization. View historical data on Jia Jie Biomedical Co and its competitors. According to the industry distribution chart, Jia Jie Biomedical Co ranks #1461 out of 1983 companies in the Consumer Packaged Goods industry, placing it in the top 73.7%.
Is Jia Jie Biomedical Co's FCF Yield % too high?
Jia Jie Biomedical Co's current FCF Yield % is -4.44. Based on the distribution chart, Jia Jie Biomedical Co ranks #1461 out of 1983 companies in the Consumer Packaged Goods industry, which is below the industry midpoint. Overall, Jia Jie Biomedical Co has a GF Score™ of 66/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Jia Jie Biomedical Co's FCF Yield % compare to KHC and GIS?
According to the Consumer Packaged Goods industry distribution chart, Jia Jie Biomedical Co ranks #1461 out of 1983 companies for FCF Yield %. This places Jia Jie Biomedical Co in the lower half of its industry. The industry median FCF Yield % is 2.05. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good FCF Yield % for a Consumer Packaged Goods company?
The median FCF Yield % among Consumer Packaged Goods companies is 2.05, based on 1,983 companies in the industry. Companies in the top quartile (top 25%) have a FCF Yield % significantly above this median, while those in the bottom quartile fall well below. However, FCF Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high FCF Yield % mean?
A high FCF Yield % can signal that a stock is expensive relative to its fundamentals. FCF Yield is calculated as Free Cash Flow divided by Market Capitalization. View historical data on Jia Jie Biomedical Co and its competitors. For the Consumer Packaged Goods industry, the median FCF Yield % is 2.05 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Jia Jie Biomedical Co's current FCF Yield % is -4.44. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Jia Jie Biomedical Co stock overvalued right now?
Based on GuruFocus' analysis, Jia Jie Biomedical Co (ROCO:4109) is currently considered Modestly Undervalued. The stock's GF Value™ is NT$16.92, compared to a current price of NT$12.15 — trading 28.2% below its estimated fair value. The current FCF Yield % is -4.44. Jia Jie Biomedical Co's overall GF Score™ is 66/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is FCF Yield % calculated?
FCF Yield % is calculated from a company's financial statements. For Jia Jie Biomedical Co (ROCO:4109), the current FCF Yield % is -4.44 as of Jul. 08, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Jia Jie Biomedical Co (ROCO:4109) Overvalued in 2026?
Based on GuruFocus' analysis, Jia Jie Biomedical Co stock appears to be undervalued.
The current stock price of NT$12.15 is trading 28.2% below its estimated GF Value™ of NT$16.92.
GuruFocus considers Jia Jie Biomedical Co to be Modestly Undervalued.
Key valuation signals for ROCO:4109:
FCF Yield %: -4.44
GF Value™: NT$16.92 vs. price of NT$12.15 (28.2% below fair value)
No single metric tells the full story. See the ROCO:4109 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Jia Jie Biomedical Co Ltd is a Taiwan-based company. The Company is engaged in the processing, sale, and trading of softshell turtle food, the Manufacture of Dairy Products, and miscellaneous food manufacturing (e.g., softshell turtle egg powder capsules, enzyme powder, tortoise jelly, softshell turtle oil, and powder capsules). The company is also engaged in the import, export of the aforementioned products, the distribution, bidding, and quotation of aforementioned products for domestic and foreign manufacturers, Wholesale of Nonalcoholic Beverages, candy wholesale, baked food wholesale, supplementary food wholesale, cosmetics wholesale, and sports equipment wholesale.
66GF Score
Get the complete analysis for ROCO:4109
FCF Yield % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ROCO:4109 has been successfully added to your 
